News · Bispecific Antibody
285 stories
Oct 13, 26Vir CEO sees ‘opportunity to do more deals’ after striking $1.9B Gilead pact for dual-masked TCEs
Oct 8, 26Ono pays $80M for regional rights to trio of Biohaven IgG degraders, including phase 3 Grave’s asset